🔎 Trials Near Me

ホーム › 心血管疾患 › コネチカット州

コネチカット州における心血管疾患の臨床試験

コネチカット州内の拠点で、心血管疾患に関する17件の研究が参加者を募集しています。

コネチカット州内の都市

公式研究テキスト(英語)

ELEVATE-HFpEF Clinical Study

  • Hartford Hospital, Hartford
被験者募集中
40歳以上 · 全性別 · 2026/10/02更新 · NCT06678841

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Cardiology Physicians of Fairfield County - Bridgeport, Bridgeport
  • CMR of Greater New Haven, LLC, Hamden
  • Cardiology Associates of Fairfield County, Stamford
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07064473

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

  • Bridgeport Hospital, Bridgeport
  • Nuvance Health- Danbury Hospital, Danbury
  • Cardiology Associates of Fairfield County, Stamford
被験者募集中第4相
18歳以上 · 全性別 · 2026/09/28更新 · NCT06909565

Product Surveillance Registry

  • Darien
  • Hartford
  • New Haven
被験者募集中観察研究
全年齢 · 全性別 · 2026/09/18更新 · NCT01524276

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  • Clinical Trial Site, Bridgeport
  • Clinical Trial Site, Waterbury
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07181109

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

  • Hartford Hospital, Hartford
  • Yale New Haven Hospital, New Haven
被験者募集中
18歳以上 · 全性別 · 2026/09/15更新 · NCT03242642

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

  • Bridgeport Hospital, Bridgeport
  • Hartford Hospital, Hartford
  • Chase Medical Research LLC, Waterbury
被験者募集中第3相
18歳〜100歳 · 全性別 · 2026/09/04更新 · NCT07517263

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

  • Yale University, New Haven
  • VA Connecticut Healthcare System, West Haven
被験者募集中第4相健康なボランティア歓迎
75歳以上 · 全性別 · 2026/09/01更新 · NCT04262206

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

  • Connecticut Children's Medical Center, Hartford
  • Yale University, New Haven
被験者募集中観察研究
7歳以上 · 全性別 · 2026/08/25更新 · NCT05705531

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

  • Research Site, Waterbury
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/24更新 · NCT07000357

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

  • Gandelman Cardiology, PC, Greenwich
  • ClinTrial Hamden, Hamden
  • Chase Medical Research LLC, Waterbury
被験者募集中第3相
50歳〜105歳 · 全性別 · 2026/08/21更新 · NCT07136012

A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors

  • UConn Health, Farmington
  • Hartford HealthCare, Hartford
  • University of Connecticut, Storrs
被験者募集中
18歳〜64歳 · 全性別 · 2026/08/12更新 · NCT07238556

Global Paradise System US Post Approval Study

  • Bridgeport Hosptial, Bridgeport
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/12更新 · NCT06297291

The Oxford Risk Factors And Non-Invasive Imaging Study

  • Yale University, School of Medicine, New Haven
被験者募集中観察研究
18歳〜99歳 · 全性別 · 2026/07/31更新 · NCT05169333

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial

  • Bridgeport Hospital, Bridgeport
被験者募集中第3相
35歳〜80歳 · 全性別 · 2026/04/16更新 · NCT07293260

MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

  • Yale University / Yale New Haven Hospital, New Haven
被験者募集中
18歳〜110歳 · 全性別 · 2025/02/25更新 · NCT05908331

PARTNER 3 Trial - Aortic Valve-in-Valve

  • Hartford Hospital, Hartford
被験者募集中
全年齢 · 全性別 · 2024/05/10更新 · NCT03003299

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。